Announcements Trials
Browse Landscape

Phase

Phase 2 120Phase 3 53Phase 1/2 28Phase 1 25Phase 2/3 5Phase 4 3Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Prostatic Neoplasms 3Prostate Cancer Metastatic 2Myasthenia Gravis 2Multiple Myeloma 2Waldenstrom Macroglobulinemia 1Subcutaneous panniculitis-like T-cell lymphoma 1Skin Neoplasms 1Prostatic Neoplasms, Castration-Resistant 1Pneumonia 1Pituitary Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lung Neoplasms 1Lung Diseases, Interstitial 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Enteropathy-Associated T-Cell Lymphoma 1Dementia 1Craniopharyngioma 1Cognitive Dysfunction 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Adrenal Insufficiency 1

Interventions

Zoledronic Acid 14Leuprolide 9bicalutamide 6Triptorelin Pamoate 6Goserelin 6luprolide acetate gel depot 5enzalutamide 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5Dutasteride 5fluciclovine F-18 3darolutamide 3Sodium Chloride 3Prednisone 3Magnetic Resonance Spectroscopy 3Flutamide 3Androgen Antagonists 3Abiraterone Acetate 32-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3cabazitaxel 2Propofol 2Prednisolone 2Lidocaine 2Gonadotropin-Releasing Hormone 2Finasteride 2Dexamethasone 2Desflurane 2Ciprofloxacin 2testosterone 17 beta-cypionate 1semaglutide 1polyethylene glycol 3350 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Prostatic Neoplasms × Prednisone × Clear all
NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Northwestern University

Phase 4 Active not recruiting
100 enrolled
Genitourinary

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

NCT01995513 2023-09-18

PLATO

Pfizer

Phase 4 Completed
509 enrolled 18 charts
Genitourinary

Prostatic Neoplasms

NCT01649635 2016-07-06

PROSPECTA

Sanofi

Phase 4 Completed
45 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡